BTIG Reiterates Buy on Evolus, Maintains $13 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.5%

Neg 0% Neu 89.5% Pos 0%

BTIG analyst Sam Eiber reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $13 price target.

Comments

No comments yet. Be the first!